schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
. of migraine. more than 4 million of them have at least 15 migraine days each month. even though many drugs prevent and treat these headaches,
.
.
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
editor's six of the best
.
"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death.
.